Skip to main content
Fig. 1 | Microbial Cell Factories

Fig. 1

From: Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus

Fig. 1

Differences in product titer and quality among three non-replicating rotavirus vaccine (NRRV) serotypes provide case studies for sequence engineering. a Diagram of the three NRRV subunit vaccine antigens. AA = amino acid. b Percent identity of amino acid sequences between the three subunit antigens. c SDS-PAGE of the initial expression of each NRRV antigen. Expression from two clones is shown for each antigen. d Diagram of a design cycle for sequence engineering

Back to article page

Microbial Cell Factories

ISSN: 1475-2859

Contact us